Literature DB >> 10854796

Abnormal cerebral neuronal migration in a rat model of intrauterine growth retardation induced by synthetic thromboxane A(2).

J Sasaki1, E Fukami, S Mimura, M Hayakawa, J Kitoh, K Watanabe.   

Abstract

Many reports have associated intrauterine growth retardation (IUGR) with adverse neurological outcome, but the underlying pathology is imperfectly understood. We have developed a new rat model of IUGR using maternal administration of synthetic thromboxane A(2) (STA(2)). In the present study, the effect of this insult on neuronal migration in the rat cerebral cortex was examined. Bromodeoxyuridine (BrdU), a time-specific cell marker was administered intraperitoneally to the mothers on embryonic day (E) 19. At postnatal day (P) 3, P4, P5, and P6, pups were terminally anesthetized and brains were removed. BrdU-labeled cells were detected immunohistochemically and counted in cerebrum, which was divided into the cortical plate (CP), the intermediate zone, and the subventricular/ventricular zone (SVZ+VZ). Numbers of labeled cells in the three areas over time were compared between IUGR and control animals. Numbers of labeled cells in SVZ+VZ were significantly greater in IUGR than in controls at P3, 5, and 6 (P<0.05). In contrast, labeled cells in the CP were significantly less abundant in IUGR animals than in controls at P3, 4, and 6 (P<0.05). We concluded that neuronal migration was delayed in IUGR rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854796     DOI: 10.1016/s0378-3782(00)00069-4

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  5 in total

Review 1.  Development of the cerebral cortex and the effect of the intrauterine environment.

Authors:  Sebastian Quezada; Margie Castillo-Melendez; David W Walker; Mary Tolcos
Journal:  J Physiol       Date:  2018-11-02       Impact factor: 5.182

2.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

3.  Global and regional differences in brain anatomy of young children born small for gestational age.

Authors:  Henrica M A De Bie; Kim J Oostrom; Maria Boersma; Dick J Veltman; Frederik Barkhof; Henriette A Delemarre-van de Waal; Martijn P van den Heuvel
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

4.  MCT8 expression in human fetal cerebral cortex is reduced in severe intrauterine growth restriction.

Authors:  Shiao Y Chan; Laura A Hancox; Azucena Martín-Santos; Laurence S Loubière; Merlin N M Walter; Ana-Maria González; Phillip M Cox; Ann Logan; Christopher J McCabe; Jayne A Franklyn; Mark D Kilby
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

5.  Role for the thromboxane A2 receptor β-isoform in the pathogenesis of intrauterine growth restriction.

Authors:  Katie L Powell; Veronica Stevens; Dannielle H Upton; Sharon A McCracken; Ann M Simpson; Yan Cheng; Vitomir Tasevski; Jonathan M Morris; Anthony W Ashton
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.